Focus

Everest Medicines Presents Complete Maintenance Period Data for Etrasimod at ECCO 2025

Data confirms significant clinical and endoscopic benefits of etrasimod 2mg after 40 weeks of maintenance treatment

Focus

Feb 26, 2025

HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies

CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Feb. 26,2025-- HBM Alpha Therapeutics (HBMAT),Inc.,an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142),announced a strateg

Focus

Feb 26, 2025

STAK Inc. Announces Pricing of Initial Public Offering

CHANGZHOU,China,Feb. 26,2025-- STAK Inc. (the "Company" or "STAK"),a fast-growing company specializing in the research,development,manufacturing,and sale of oilfield-specialized pr

Focus

Feb 26, 2025

Moloco Commerce Media and MetaRouter Partner to Drive Privacy-First Ad Personalization at Scale

MetaRouter provides customer data infrastructure to power Moloco\'s ad personalization with full customer consent and privacy protections

Focus

Feb 26, 2025

"Demon child" Nezha: How he captured the hearts of global viewers

BEIJING,Feb. 21,2025-- A news report fromChina.org.cn on the Chinese blockbuster "Ne Zha 2":

Focus

Feb 25, 2025

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 21ST

NEW YORK,Feb. 21,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insight

Focus

Feb 25, 2025

1 ... 58 59 60 61 62 63 64 ... 118